Alexander Scholten

Title: Alexander Scholten: Innovator in Cardiovascular Research

Introduction

Alexander Scholten is a notable inventor based in Dormagen, Germany. He has made significant contributions to the field of cardiovascular research through his innovative work in nucleic acids and ion channels. With a total of 2 patents, Scholten's inventions are paving the way for advancements in medical treatments.

Latest Patents

Scholten's latest patents focus on isolated or purified human nucleic acids, particularly DNA that encodes ion channels. One of his inventions relates to a vector that includes this nucleic acid, a host cell containing the vector, and a composition that combines the nucleic acid with a carrier. This invention also encompasses a polypeptide or protein encoded by the nucleic acid, along with methods for treating mammals suffering from cardiovascular disorders. Another patent involves a nucleic acid that comprises part of the sequence of an ion channel, which may be derived from various sources, including human and animal DNA. This invention also includes mRNA molecules containing the corresponding sequences and highlights the use of these nucleic acids and proteins for screening, diagnosing methods, and treatment of cardiovascular disorders.

Career Highlights

Alexander Scholten is affiliated with Forschungszentrum Jülich GmbH, where he continues to engage in groundbreaking research. His work is characterized by a strong focus on the molecular mechanisms underlying cardiovascular health.

Collaborations

Scholten collaborates with esteemed colleagues, including Renate Gauss and Wolfgang Bönigk, to further enhance the impact of his research in the scientific community.

Conclusion

Alexander Scholten's innovative contributions to cardiovascular research through his patents demonstrate his commitment to advancing medical science. His work not only highlights the importance of nucleic acids in treatment but also showcases the collaborative spirit of scientific inquiry.